The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT‐1001 in coeliac disease subjects: a proof of concept study
Open accessAbstract
Summary: Background: Lifelong adherence to a strict gluten‐free diet is the cornerstone of coeliac disease treatment. Elucidation of disease pathogenesis has created opportunities for novel therapeutic approaches to coeliac disease. AT‐1001 is an inhibitor of paracellular permeability whose structure is derived from a protein secreted by Vibrio cholerae . Aim: To determine the safety and tolerability of 12 mg doses of AT‐1001 in coeliac disease subjects challenged with gluten. Methods: An in‐patient, double‐blind, randomized placebo‐controlled safety study utilizing intestinal permeability, measured via fractional excretions of lactulose and mannitol, as an exploratory measure of drug efficacy. Results: Compared to placebo, no increase in adverse events occurred in patients exposed to AT‐1001. Following acute gluten exposure, a 70% increase in intestinal permeability was detected in the placebo group, while none was seen in the AT‐1001 group. Interferon‐γ levels increased in four of seven patients (57%) of the placebo group, but only in four of 14 patients (29%) of the AT‐1001 group. Gastrointestinal symptoms were more frequently detected in the placebo group when compared to the AT‐1001 group ( P = 0.018). Conclusions: AT‐1001 is well tolerated and appears to reduce intestinal barrier dysfunction, proinflammatory cytokine production, and gastrointestinal symptoms in coeliacs after gluten exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maiuri, L., Ciacci, C., Ricciardelli, I., Vacca, L., Raia, V., Auricchio, S., Picard, J., Osman, M., Quaratino, S., & Londei, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13803-2 · Cited by 612
Drago, S., El Asmar, R., Di Pierro, M., Grazia Clemente, M., Sapone, A. T. A., Thakar, M., Iacono, G., Carroccio, A., D'Agate, C., Not, T., et al. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500235334 · Cited by 502
Self-citationA porous defense: the leaky epithelial barrier in intestinal disease
Clayburgh, D. R., Shen, L., & Turner, J. R. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700050 · Cited by 498
Human zonulin, a potential modulator of intestinal tight junctions
Wang, W., Uzzau, S., Goldblum, S. E., & Fasano, A. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.24.4435 · Cited by 470
Self-citationClemente, M. G. (2003) · Gut · doi:10.1136/gut.52.2.218 · Cited by 412
Watts, T., Berti, I., Sapone, A., Gerarduzzi, T., Not, T., Zielke, R., & Fasano, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500178102 · Cited by 313
Self-citationLammers, K. M., Brigidi, P., Vitali, B., Gionchetti, P., Rizzello, F., Caramelli, E., Matteuzzi, D., & Campieri, M. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00144-5 · Cited by 284
Self-citationMonsuur, A. J., Bakker, P. I. W. D., Alizadeh, B. Z., Zhernakova, A., Bevova, M. R., Strengman, E., Franke, L., Slot, R. V., Belzen, M. J. V., Lavrijsen, I. C. M., et al. (2005) · Nature Genetics · doi:10.1038/ng1680 · Cited by 242
Thomas, K. E., Sapone, A., Fasano, A., & Vogel, S. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2512 · Cited by 231
Self-citationFasano, A., Uzzau, S., Fiore, C., & Margaretten, K. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041245 · Cited by 172
Self-citation
Cited by
Ludvigsson, J. F., Bai, J. C., Biagi, F., Card, T. R., Ciacci, C., Ciclitira, P. J., Green, P. H. R., Hadjivassiliou, M., Holdoway, A., van Heel, D. A., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306578 · Cited by 1,116
Celiac disease: a comprehensive current review
Caio, G., Volta, U., Sapone, A., Leffler, D. A., De Giorgio, R., Catassi, C., & Fasano, A. (2019) · BMC Medicine · doi:10.1186/s12916-019-1380-z · Cited by 1,105
Self-citationFasano, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2008 · Cited by 1,003
Self-citationCeliac disease: Prevalence, diagnosis, pathogenesis and treatment
Gujral, N. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i42.6036 · Cited by 690
Celiac Disease: From Pathogenesis to Novel Therapies
Schuppan, D., Junker, Y., & Barisani, D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.008 · Cited by 606
Metadata
- Authors
- PATERSON, B. M., LAMMERS, K. M., ARRIETA, M. C., FASANO, A., & MEDDINGS, J. B.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2007-06-19
- Volume
- 26
- Issue
- 5
- Pages
- 757-766
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W1540991136
- Cited by
- 279
- References
- 15
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT‐1001 in coeliac disease subjects: a proof of concept study. https://app.cochat.ai/papers/10.1111/j.1365-2036.2007.03413.x
- The paper
- PATERSON, B. M., LAMMERS, K. M., ARRIETA, M. C., FASANO, A., & MEDDINGS, J. B. (2007). The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT‐1001 in coeliac disease subjects: a proof of concept study. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2007.03413.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.